Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (…

Background In people who are infected with the hepatitis C virus (HCV), chronic infection
often develops and is difficult to eradicate. We sought to determine whether treatment during …

Background Since the release of the first global hepatitis elimination targets in 2016, and until
the COVID-19 pandemic started in early 2020, many countries and territories were making …

The treatment of hepatitis C has dramatically improved over the past decade. Unlike any
other chronic viral infection, a significant proportion of patients with chronic hepatitis C can be …

The coronavirus disease 2019 (COVID-19) pandemic poses an enormous challenge to
healthcare systems in affected communities. Older patients and those with pre-existing medical …

Antiviral T cells are thought to regulate whether hepatitis C virus (HCV) and human
immunodeficiency virus (HIV) infections result in viral control, asymptomatic persistence or severe …

Longitudinal analyses of the innate immune system, including the earliest time points, are
essential to understand the immunopathogenesis and clinical course of coronavirus disease (…

Background and Aim: Decisions on public health issues are dependent on reliable
epidemiological data. A comprehensive review of the literature was used to gather country‐specific …

BACKGROUND & AIMS: The quantifiable level of HBsAg has been suggested as a predictor
of treatment response in chronic hepatitis B. However, there is limited information on HBsAg …

The disease burden of hepatitis C virus ( HCV ) is expected to increase as the infected population
ages. A modelling approach was used to estimate the total number of viremic infections…